Immucell (ICCC) Capital Expenditures Growth (1y) (2011 - 2025)
Powered by 
Analysis
Immucell (ICCC) Capital Expenditures Growth (1y) (2011 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn | -27.73% |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn | -19.86% |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn | -42.11% |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn | 43.58% |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn | - |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -12.19% |
| Sep 30, 2025 | 571.77% |
| Jun 30, 2025 | 40.11% |
| Mar 31, 2025 | 367.69% |
| Dec 31, 2024 | 141.22% |
| Sep 30, 2024 | -78.98% |
| Jun 30, 2024 | -84.37% |
| Mar 31, 2024 | -89.69% |
| Dec 31, 2023 | -94.54% |
| Sep 30, 2023 | -42.73% |
| Jun 30, 2023 | -24.89% |
| Mar 31, 2023 | -15.52% |
| Dec 31, 2022 | 111.49% |
| Sep 30, 2022 | 8.72% |
| Jun 30, 2022 | 7.27% |
| Mar 31, 2022 | 131.16% |
| Dec 31, 2021 | 147.50% |
| Sep 30, 2021 | -54.15% |
| Jun 30, 2021 | -17.25% |
| Mar 31, 2021 | -72.10% |